Exact Mass: 320.0508462
Exact Mass Matches: 320.0508462
Found 500 metabolites which its exact mass value is equals to given mass value 320.0508462
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
trans-3,3',4',5,5',7-Hexahydroxyflavanone
(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration. It has a role as a metabolite, an antioxidant and an antineoplastic agent. It is a secondary alpha-hydroxy ketone and a dihydromyricetin. It is an enantiomer of a (-)-dihydromyricetin. Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus). Dihydromyricetin is a naturally occurring flavonoid found in the many plant species and is thought to be the active ingredient of several traditional Japanese, Chinese, and Korean medicines that are used to treat fever, parasite infections, liver diseases, and hangovers. Dihydromyricetin preparations have not been linked to instances of serum enzyme elevations or clinically apparent liver injury with jaundice. Dihydromyricetin is a natural product found in Vitis rotundifolia, Catha edulis, and other organisms with data available. (±)-trans-3,3,4,5,5,7-Hexahydroxyflavanone is found in tea. (±)-trans-3,3,4,5,5,7-Hexahydroxyflavanone is a constituent of Camellia sinensis (Chinese green tea). Constituent of Camellia sinensis (Chinese green tea). (±)-Dihydromyricetin is found in tea. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
Coptisine
C19H14NO4+ (320.09227840000005)
Coptisine is an alkaloid. It has a role as a metabolite. Coptisine is a natural product found in Fumaria capreolata, Fumaria muralis, and other organisms with data available. See also: Sanguinaria canadensis root (part of); Chelidonium majus flowering top (part of). A natural product found in Coptis japonica.
Phenthoate
C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
2,3-Dihydrogossypetin
A member of the class of dihydroflavonols that is the 2,3-dihydro derivative of gossypetin.
lorazepam
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; INTERNAL_ID 1512 CONFIDENCE standard compound; INTERNAL_ID 8600 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3138
Lorazepam
Lorazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. [PubChem]Lorazepam binds to an allosteric site on GABA-A receptors, which are pentameric ionotropic receptors in the CNS. Binding potentiates the effects of the inhibitory neurotransmitter GABA, which upon binding opens the chloride channel in the receptor, allowing chloride influx and causing hyperpolerization of the neuron. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics
7-Hydroxy-6-methoxy-alpha-pyrufuran
7-Hydroxy-6-methoxy-alpha-pyrufuran is found in fruits. 7-Hydroxy-6-methoxy-alpha-pyrufuran is a constituent of the sapwood of Mespilus germanica (European medlar). Constituent of the sapwood of Mespilus germanica (European medlar). 7-Hydroxy-6-methoxy-alpha-pyrufuran is found in fruits.
Erosnin
Erosnin is found in jicama. Erosnin is a constituent of the yam bean (Pachyrrhizus erosus) Constituent of the yam bean (Pachyrrhizus erosus). Erosnin is found in jicama and pulses.
3-p-Coumaroyl-1,5-quinolactone
3-p-Coumaroyl-1,5-quinolactone is a polyphenol compound found in foods of plant origin (PMID: 20428313)
4-p-Coumaroyl-1,5-quinolactone
4-p-Coumaroyl-1,5-quinolactone is a polyphenol compound found in foods of plant origin (PMID: 20428313)
5-Amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one
C16H11F3N2O2 (320.07725819999996)
7-(Benzyloxy)-4-(trifluoromethyl)-2H-chromen-2-one
Lonidamine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000988 - Antispermatogenic Agents D011838 - Radiation-Sensitizing Agents C1744 - Multidrug Resistance Modulator D000970 - Antineoplastic Agents Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki: 2.5 μM). Lonidamine also inhibits aerobic glycolysis in cancer cells. Lonidamine can be used in the research of mitochondrial metabolism and inflammation, such as pulmonary fibrosis[1][2][3].
(S)-4-(2,4-Difluoro-5-(pyrimidin-5-yl)phenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine
C15H14F2N4S (320.09071880000005)
(2S)-4,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-one
2-[1-(2-Fluorophenyl)ethylamino]-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4-one
Ethyl brevifolincarboxylate
Ethyl brevifolincarboxylate, also known as ebfc, belongs to isocoumarins and derivatives class of compounds. Those are polycyclic compounds containing an isochromane which bears a ketone at the carbon C1. Ethyl brevifolincarboxylate is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Ethyl brevifolincarboxylate can be found in pomegranate, which makes ethyl brevifolincarboxylate a potential biomarker for the consumption of this food product.
4'-Methylepigallocatechin
A polyphenol metabolite detected in biological fluids [PhenolExplorer]
4-coumaroylshikimate
4-coumaroylshikimate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4-coumaroylshikimate can be found in a number of food items such as arctic blackberry, spinach, prickly pear, and java plum, which makes 4-coumaroylshikimate a potential biomarker for the consumption of these food products.
4-benzoyloxymethyl-3,8-dioxatricyclo[5.1.0.02,4]octane-5,6-diol 5-acetate
cis-2-(3,4-dihydroxy-5-methoxyphenyl)-3,4-dihydro-2H-1-Benzopyran-3,5,7-triol
Gallocatechin 4-methyl ether
Ourateacatechin
ampelopsin
Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
Methyl 2-cyano-3-{1-[4-(trifluoromethyl)phenyl]-1H-pyrrol-2-yl}acrylate
C16H11F3N2O2 (320.07725819999996)
1-(3-methoxyphenyl)-3-(methyl-oxo-phenyl-$l^{6}-sulfanylidene)thiourea
C15H16N2O2S2 (320.06531559999996)
barceloneic acid A
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates
(-)-2,3-cis-3,4-cis-4-methoxy-3,3,4,7,8-pentahydroxyflavan
3,5,7,3,5-Pentahydroxy-4-methoxy-(-)-epicatechin (richtig aber: 5-Hydroxy-(-)-epicatechin-4-methylaether)|(-)-4-methylepigallocatechin|4-O-methyl-(-)-epigallocatechin|4-O-methyl-epigallocatechin|4-O-methylepigallocatechin|Ourateacatechin
2,5,7-Trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-on|2,5,7-trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-one
7-methoxy-6-[1,4-dihydro-3-methyl-3-methoxy-2-hydroxy-4-oxo-1-furanyl]coumarin|micromeloside B
(3R*,4R*)-3-(3,4-dihydroxybenzyl)-3,4,7,8-tetrahydroxychroman|epihaematoxylol
(1S)-1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-6,9-dihydro-1H-naphtho[2,3-c]pyran-6,9-dione|coronatoquinone
9H-Xanthen-9-one, 5-chloro-8-hydroxy-1,4-dimethoxy-3-methyl-
3-Chloro-1, 2, 4, 5-tetrahydroxy-7-methylanthraquinone
2-chloro-1-hydroxy-3,6-dimethoxy-8-methyl-xanthen-9-one|2-Chloro-3, 6-di-O-methylnorlichexanthone
7-Hexanoyl-2,5,7,8-tetrahydroxy-1,4-naphthoquinone
1,4,8-Trihydroxy-3-methyl-9-oxo-3,4-dihydro-2H-xanthene-4a(9H)-carboxylic acid methyl ester
16-bromo-(7E,11E,15E)-hexadeca-7,11,15-trien-5,13-diynoic acid
4-dechloro-8-O-methylthiomelin|5, 8-Di-Me ether-2-Chloro-1, 5, 8-trihydroxy-6-methylxanthone
5,6-anhydrolandomycinone
A natural product found in Streptomyces cyanogenus.
3-(4-hydroxyphenyl)-2,3-dihydroxy-1-(4,6-dihydroxy-2-methoxyphenyl)-1-propanone|7-3028/6
(1R,3S)-5,10-dihydroxy-1-methyl-6,9-dioxo-3,4,6,7,8,9-hexahydro-1H-naphtho[2,3-c]pyran-3-yl acetic acid
2-(3,4-dihydroxy-phenyl)-7-methoxy-chroman-3,4,5-triol
(Z)-4-hydroxy-3-(7-hydroxy-4-chromoyl)-hex-2-enedioic acid
7-methoxy-8-(1S*,3-dihydroxy-2S*-acetyl-3-butenyl)coumarin|omphalocarpinol
8-Me ether-(2R,3S,4S)-3,3,4,4,7,8-Hexahydroxyflavan
rel-(1R,5S)-3-(1-acetoxybutyl)-4-bromo-5-methyl-5-methoxy-2(5H)-furanone
4-Hydroxy-3-methoxy-5-phenyl-1,8-naphthalic anhydride
2-(2-Methyl-2-propenoyl),2-Ac,Me ester-2-Hydroxy-5-(hydroxyacetyl)benzoic acid|caleteucrifolone
Dihydromyricetin
A hexahydroxyflavanone that is the 2,3-dihydro derivative of myricetin. Dihydromyricetin, also known as ampelopsin or (2r,3r)-3,5,7,3,4,5-hexahydroxyflavanone, is a member of the class of compounds known as epigallocatechins. Epigallocatechins are compounds containing epigallocatechin or a derivative. Epigallocatechin is a flavan-3-ol containing a benzopyran-3,5,7-triol linked to a 3,4,5-hydroxyphenyl moiety. Dihydromyricetin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Dihydromyricetin can be found in a number of food items such as highbush blueberry, summer grape, sacred lotus, and sweet rowanberry, which makes dihydromyricetin a potential biomarker for the consumption of these food products. Hovenia dulcis has been used in traditional Japanese, Chinese, and Korean medicines to treat fever, parasitic infection, as a laxative, and a treatment of liver diseases, and as a hangover treatment. Methods have been developed to extract ampelopsin from it at large scales, and laboratory research has been conducted with the compound to see if it might be useful as a drug in any of the conditions for which the parent plant has been traditionally used . Isolated from flowers of Eugenia jambolana (jambolan). trans-3,3,4,5,5,7-Hexahydroxyflavanone is found in fruits. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
(E)-2,5-dihydroxy-7-methoxy-3-methoxymethylene-2-(2-oxopropyl)-2,3-dihydro[1,4]naphthoquinone|ascomycone C
Ellagic acid hydrate
Lonidamine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000988 - Antispermatogenic Agents D011838 - Radiation-Sensitizing Agents C1744 - Multidrug Resistance Modulator D000970 - Antineoplastic Agents Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki: 2.5 μM). Lonidamine also inhibits aerobic glycolysis in cancer cells. Lonidamine can be used in the research of mitochondrial metabolism and inflammation, such as pulmonary fibrosis[1][2][3].
2-hydroxy-6-[2-hydroxy-6-(hydroxymethyl)-4-methoxyphenoxy]-4-methylbenzoic acid
2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione
2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione_major
Fenirofibrate
C17H17ClO4 (320.08153120000003)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent
Gly-His-OH
C13H12N4O6 (320.07568119999996)
3-Coumaroylquinic acid lactone
4-Coumaroylquinic acid lactone
7-Hydroxy-6-methoxy-a-pyrufuran
16-bromo-7E,11E,15E-hexadecatrien-5,13-diynoic acid
16-bromo-7E,11E,15Z-hexadecatrien-5,13-diynoic acid
1-[2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL]PIPERAZINE
4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoic acid
C16H11F3N2O2 (320.07725819999996)
N-[5-Acetyl-2-(benzyloxy)phenyl]sulfuric diamide
C15H16N2O4S (320.08307360000003)
[4-[3,5-bis(trifluoromethyl)phenyl]phenyl]methanol
1-(5-BROMO-1H-INDOL-3-YL)-2-(PYRROLIDIN-1-YL)ETHANE-1,2-DIONE
3-(3-amino-1-(4-chlorophenyl)butan-2-yl)benzonitrile HCl salt
N-[6-[(2-chloro-4-hydroxyphenyl)imino]-4-methoxy-3-oxo-1,4-cyclohexadien-1-yl]acetamide
C15H13ClN2O4 (320.05638080000006)
Etomoxir (Na salt)
C15H18ClNaO4 (320.07912580000004)
Etomoxir((R)-(+)-Etomoxir) sodium salt is an irreversible inhibitor of carnitine palmitoyltransferase 1a (CPT-1a), inhibits fatty acid oxidation (FAO) through CPT-1a and inhibits palmitate β-oxidation in human, rat and guinea pig[1].
(2-(Benzyloxy)-3-bromo-5-methylphenyl)boronic acid
METHYL 3-(4-(ETHOXYCARBONYL)-3-FLUOROPHENYL)-2-FLUOROBENZOATE
Benzonitrile, 3-[(1R,2R)-2-amino-1-[(4-chlorophenyl)methyl]propyl]-, monohydrochloride, rel- (9CI)
(1S, 2S)-1,2-Bis(4-fluorophenyl)ethylenediamine dihydrochloride
bis(pentane-2,4-dionato-O,O)(propane-1,3-diolato-O,O)titanium
((7-Oxo-7H-benz(de)anthracen-3-yl)thio)acetic acid
LY2811376
C15H14F2N4S (320.09071880000005)
4-[2-chloro-6-(3-nitrophenyl)pyrimidin-4-yl]morpholine
(4-((TERT-BUTYLDIMETHYLSILYL)OXY)-3,5-DICHLOROPHENYL)BORONIC ACID
C12H19BCl2O3Si (320.05735139999996)
4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenamine
Ethyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate
C15H13ClN2O4 (320.05638080000006)
Ethyl [(4-chloro-3-cyano-6-methoxy-7-quinolinyl)oxy]acetate
C15H13ClN2O4 (320.05638080000006)
4-Chloro-1-((3-(trifluoromethyl)phenoxy)Methyl)-1H-pyrazole-3-carboxylic acid
Benzonitrile, 3-[(1S,2S)-2-amino-1-[(4-chlorophenyl)methyl]propyl]-, hydrochloride (1:1)
5-(2-chlorophenyl)-7-ethyl-1H-thieno[2,3-e][1,4]diazepine-2(3H)-thione
1,4-Benzodioxin-2-methanol, 2,3-dihydro-, 4-methylbenzenesulfonate
C16H16O5S (320.07184060000003)
methyl 2,3,4-tri-o-acetyl-1-thio-beta-l-fucopyranoside
C13H20O7S (320.09296900000004)
1-bromo-2-fluoro-4-(4-pentylphenyl)benzene
C17H18BrF (320.05758199999997)
7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-benzo-1,4-diazepin-2-one 4-oxide
(4R,5R)-2-Chloro-1,3-dimethyl-4,5-diphenyl-1-imidazolinium Chloride
ETHYL 2-(2-(((BENZYLOXY)CARBONYL)AMINO)THIAZOL-4-YL)ACETATE
C15H16N2O4S (320.08307360000003)
1-Butanesulfonamide,N-[4-(4-cyano-2,5-dihydro-5-oxo-3-furanyl)phenyl]-
C15H16N2O4S (320.08307360000003)
2-(4-Aminophenyl)-6-methyl-1,3-benzothiazole-7-sulfonic acid
2-(4-AMINO-BENZENESULFONYLAMINO)-3-PHENYL-PROPIONIC ACID
C15H16N2O4S (320.08307360000003)
4-Hydroxy-2-phenyl-6-quinolinesulfonic acid fluoride
C15H11FNO4S- (320.03927980000003)
N-(2-Formyl-4-nitro-phenyl)-4-methyl-benzenesulfonamide
1-[4-(6-METHYL-BENZOTHIAZOL-2-YL)-PHENYL]-PYRROLE-2,5-DIONE
Methyl (E)-2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate
C15H13ClN2O4 (320.05638080000006)
2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]acetic acid
1H-PYRROLO[2,3-B]PYRIDINE, 4-CHLORO-2-METHYL-1-[(2-METHYLPHENYL)SULFONYL]-
C15H13ClN2O2S (320.03862280000004)
chloropalladium(1+),(1Z,5Z)-cycloocta-1,5-diene,2-methanidyl-2-methylpropane
methyl 12-hydroxy-6-oxonaphtho[1,2-c]isochromene-11-carboxylate
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-3-methyl-1-[(4-methylphenyl)sulfonyl]-
C15H13ClN2O2S (320.03862280000004)
2-thia-6-azaspiro[3.3]heptane hemioxalate
C12H20N2O4S2 (320.08644400000003)
Benzene, 4-(bromomethyl)-1-cyclohexyl-2-(trifluoromethyl)-
N-(3-ethynylphenyl)-7-methoxy-6-nitroquinazolin-4-amine
2-(CHLOROMETHYL)-3-(4-CHLOROPHENYL)-2-METHYL-1,2,3,4-TETRAHYDROQUINAZOLIN-4-ONE
2-dimethoxyphosphinothioylsulfanyl-2-phenylacetic acid
2-butoxyethyl 2,4-dichlorophenoxyacetate
C14H18Cl2O4 (320.05820880000005)
5-(2-CHLORO-1,1-DIMETHYLETHYL)-3-[4-(TRIFLUOROMETHOXY)PHENYL]-1,2,4-OXADIAZOLE
[4-(4-chloro-phenyl)-piperazin-1-yl]-furan-2-yl-acetic acid
C16H17ClN2O3 (320.09276420000003)
4-amino-N-[3-[(2-hydroxyethyl)sulphonyl]phenyl]benzamide
C15H16N2O4S (320.08307360000003)
METHYL 5-(2-METHOXY-2-OXOETHYL)-1-(4-NITROPHENYL)-1H-1,2,3-TRIAZOLE-4-CARBOXYLATE
C13H12N4O6 (320.07568119999996)
4-(5-(3-(TRIFLUOROMETHYL)PHENYLAMINO)-4H-1,2,4-TRIAZOL-3-YL)PHENOL
C15H11F3N4O (320.08849119999996)
Encenicline
C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist > C73579 - Nicotinic Agonist
(5s)-2-{[(1s)-1-(2-Fluorophenyl)ethyl]amino}-5-Methyl-5-(Trifluoromethyl)-1,3-Thiazol-4(5h)-One
3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-4-one
5-Amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one
C16H11F3N2O2 (320.07725819999996)
7-(Benzyloxy)-4-(trifluoromethyl)-2H-chromen-2-one
(-)-Microdiplodiasolol
A member of the class of xanthones that is 4a,9a-dihydro-1H-xanthene-2,9-dione substituted by hydroxy groups at positions 1, 8 and 9a, a methoxy group at position 4 and methyl groups at positions 4a and 6 (the 1S,4aS,9aS stereoisomer). Isolated from Microdiplodia species, it exhibits antibacterial activity.
N-(4-fluorophenyl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide
2-[(6-Butoxypyridin-3-yl)amino]-4-chlorobenzoic acid
C16H17ClN2O3 (320.09276420000003)
N-[4-[(4-hydroxyphenyl)-methylsulfamoyl]phenyl]acetamide
C15H16N2O4S (320.08307360000003)
[3-Methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone
C15H16N2O2S2 (320.06531559999996)
(7R,8R)-Alpha-Diversonolic Ester
A member of the class of xanthones that is methyl 2,3,4,9-tetrahydro-1H-xanthene-1-carboxylate substituted by hydroxy groups at positions 1, 2 and 8, a methyl group at position 6 and an oxo group at position 9 (the 1R,2R stereoisomer). It has been isolated from the sea fan derived fungus Aspergillus sydowii.
1H-Indazole-3-carboxylic acid, 1-(3,4-dichlorobenzyl)-
2-[(6-chloro-1-benzotriazolyl)oxy]-N-(4-fluorophenyl)acetamide
C14H10ClFN4O2 (320.04762819999996)
3-(2-chloro-5-oxo-10-phenothiazinyl)-N-methyl-1-propanamine
8-Chloro-10-[3-(methylamino)propyl]-10h-phenothiazin-3-ol
5-(4-Methylphenyl)-2-methylsulfonyl-3-thiophen-2-yl-3,4-dihydropyrazole
C15H16N2O2S2 (320.06531559999996)
10-(3-Aminopropyl)-8-chlorophenothiazine-2,3-dione
C15H13ClN2O2S (320.03862280000004)
D004791 - Enzyme Inhibitors > D000067956 - Adenylyl Cyclase Inhibitors
2-Chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthraquinone
N-(5-Phosphopyridoxyl)-D-alanine
C11H17N2O7P (320.07733420000005)
An alanine derivative arising from reductive N-alkylation of D-alanine by pyridoxal-5-phosphate.
N-(5-Phosphopyridoxyl)-L-alanine
C11H17N2O7P (320.07733420000005)
An alanine derivative arising from reductive N-alkylation of L-alanine by pyridoxal-5-phosphate.
N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
N-(oxan-4-ylmethyl)-5-thiophen-2-ylimidazo[2,1-b][1,3,4]thiadiazol-2-amine
C14H16N4OS2 (320.07654859999997)
2-(6-methyl-2-pyridyl)-N-pyrimidin-4-yl-thieno[3,2-d]pyrimidin-4-amine
C16H12N6S (320.08441120000003)
2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxy-2,3-dihydrochromen-4-one
7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-1H,10H-pyrano[4,3-b]chromene-9-carboxylic acid
An organic heterotricyclic compound that is 1H,10H-pyrano[4,3-b]chromene substituted by hydroxy groups at positions 7 and 8, a methoxy group at position 1, a methyl group at position 3 and an oxo group at position 10. Isolated from Chaetomium funicola, it exhibits inhibitory activity against metallo-beta-lactamases.
gamma-L-Glutamyl-L-cysteinyl-beta-alanine
C11H18N3O6S- (320.09162680000003)
Octulose 8-phosphate
A ketooctose derivative that is D-glycero-D-altro-octulose carrying a single phosphate substituent at position 8.
2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-5,6, 7,8-tetrahydroxypterin
[(2R,3R,4S,5S)-3,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl] dihydrogen phosphate
[(2R,3R,4R,5R,6S,7R)-2,3,4,5,6,7-hexahydroxy-8-oxooctyl] dihydrogen phosphate
[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-methylphenoxy)oxolan-2-yl]methyl dihydrogen phosphate
C12H17O8P (320.06610120000005)
3-[[(1S)-4-amino-1-carboxy-4-oxobutyl]carbamoyl]-3-hydroxypentanedioic acid
C11H16N2O9 (320.08557659999997)
[(2R,3R)-2,3-dihydroxy-3-[(3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]propyl] dihydrogen phosphate
(3r,4s,5r)-3,4-Dihydroxy-5-{[(2e)-3-(4-Hydroxyphenyl)prop-2-Enoyl]oxy}cyclohex-1-Ene-1-Carboxylic Acid
4-fluoro-N-(7-methyl-4-oxo-2-thieno[3,2-d][1,3]thiazinyl)benzamide
C14H9FN2O2S2 (320.00894659999994)
1-(3-Chlorophenyl)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)thiourea
C15H13ClN2O2S (320.03862280000004)
2-chloro-N-[(2-hydroxy-5-methylphenyl)carbamothioyl]benzamide
C15H13ClN2O2S (320.03862280000004)
2-[(3-Oxo-5-phenyl-1,2-dihydropyrazol-4-yl)-(3-thiophenyl)methyl]propanedinitrile
C17H12N4OS (320.07317820000003)
5-Nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester
2-(3-Methoxyphenyl)-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole
C16H11F3N2O2 (320.07725819999996)
7-chloro-3-[2-(1-cyclohexenyl)ethyl]-2-sulfanylidene-1H-quinazolin-4-one
1-(1,2,3-Benzothiadiazol-5-yl)-3-(1-naphthalenyl)urea
C17H12N4OS (320.07317820000003)
N-(2-methoxyethyl)-1-methyl-2-oxo-6-benzo[cd]indolesulfonamide
C15H16N2O4S (320.08307360000003)
4-(2-furanyl)-N-(3-pyridinylmethyl)-6-(trifluoromethyl)-2-pyrimidinamine
C15H11F3N4O (320.08849119999996)
1-Naphthalen-2-yl-2-(9H-purin-6-ylsulfanyl)-ethanone
C17H12N4OS (320.07317820000003)
(2S,5R,6R)-6-[(4-hydroxybenzylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C15H16N2O4S (320.08307360000003)
Ascomycotin A
An organic heterotricyclic compound that is 3,4-dihydro-2H,5H-pyrano[3,2-c]chromene substituted by methyl, oxo, hydroxy, methoxy and methoxycarbonyl groups at positions 2R, 4, 7, 8 and 10, respectively. It is isolated from the fungal strain Ascomycota sp. Ind19F07, which was isolated from the deep sea sediment of the Indian Ocean.
4-chloro-N-[(E)-[(E)-3-phenylprop-2-enylidene]amino]benzenesulfonamide
C15H13ClN2O2S (320.03862280000004)
[(E)-1-(4-methoxyphenyl)-3-phenylprop-2-enyl] hydrogen sulate
C16H16O5S (320.07184060000003)
N-[(Z)-(2-hydroxy-3-methoxy-5-nitrophenyl)methylideneamino]-2-(1,2,4-triazol-1-yl)acetamide
1-[(2,4-dichlorophenyl)methyl]-3-[(E)-2-phenylethenyl]urea
3-(3,4-Dihydroxyphenyl)-1-(2,3,4,5,6-pentahydroxyphenyl)prop-2-en-1-one
[(3S,4R,5R,6R,7R)-3,4,5,6,7,8-hexahydroxy-2-oxooctyl] dihydrogen phosphate
Phenyl-3-trimethylstannylpropyl sulfide
C12H24SSn (320.06206139999995)
Ampelopsin
(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration. It has a role as a metabolite, an antioxidant and an antineoplastic agent. It is a secondary alpha-hydroxy ketone and a dihydromyricetin. It is an enantiomer of a (-)-dihydromyricetin. Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus). Dihydromyricetin is a naturally occurring flavonoid found in the many plant species and is thought to be the active ingredient of several traditional Japanese, Chinese, and Korean medicines that are used to treat fever, parasite infections, liver diseases, and hangovers. Dihydromyricetin preparations have not been linked to instances of serum enzyme elevations or clinically apparent liver injury with jaundice. Dihydromyricetin is a natural product found in Vitis rotundifolia, Catha edulis, and other organisms with data available. An optically active form of dihydromyricetin having (2R,3R)-configuration. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
dTMP(2-)
A 2-deoxyribonucleoside 5-monophosphate(2-) obtained by deprotonation of the phosphate OH groups of dTMP; major species at pH 7.3.
PHENTHOATE
C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
6beta-[(p-hydroxybenzylidene)amino]penicillanic acid
C15H16N2O4S (320.08307360000003)
Penicillanic acid carrying a (p-hydroxybenzylidene)amino substituent at the 6beta position. It has been used as a hapten in the production of a generic monoclonal antibody for determining penicillin residues in milk.
4-O-Methylepigallocatechin
A natural product found in Parapiptadenia rigida.
(2E,4E)-2,4-Dihydroxy-4-[6-(4-hydroxyphenyl)-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene]but-2-enoate
methyl 1,2,8-trihydroxy-6-methyl-9-oxo-3,4-dihydro-2h-xanthene-1-carboxylate
methyl (3e)-2-hydroxy-4-(8-hydroxy-7-methoxy-2-oxochromen-3-yl)-2-methylbut-3-enoate
methyl (1s,2s)-2,8-dihydroxy-6-(hydroxymethyl)-9-oxo-1,2,3,4-tetrahydroxanthene-1-carboxylate
2-chloro-7-hydroxy-3,9-dimethoxy-1-methylbenzo[c]chromen-6-one
2-(3,4-dihydroxyphenyl)-8-methoxy-3,4-dihydro-2h-1-benzopyran-3,4,7-triol
methyl 4,8,9-trihydroxy-6-methyl-1-oxo-3,4-dihydro-2h-xanthene-4a-carboxylate
6-(3-hydroxy-4-methoxy-4-methyl-5-oxooxolan-2-yl)-7-methoxychromen-2-one
5,7,9,10-tetrahydroxy-2-methoxy-7-methyl-6,8-dihydro-5h-anthracene-1,4-dione
(4r,4ar,9ar)-4,8,9a-trihydroxy-3-methoxy-4a,6-dimethyl-4h-xanthene-1,9-dione
6,9-dihydroxy-3,7-dimethoxy-3-methyl-1h,4h-naphtho[2,3-c]pyran-5,10-dione
1-[7,8-dihydroxy-5-(hydroxymethyl)-6-methyl-2-oxochromen-3-yl]-2-methylbutane-1,3-dione
methyl (2s,3e)-2-hydroxy-4-(7-hydroxy-8-methoxy-2-oxochromen-3-yl)-2-methylbut-3-enoate
4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid
4,5-dihydroxy-3-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohex-1-ene-1-carboxylic acid
methyl (2r)-5-hydroxy-7-methyl-4-oxo-2-[(2s)-5-oxooxolan-2-yl]-3h-1-benzopyran-2-carboxylate
methyl 2,3,8-trihydroxy-6-methyl-9-oxo-1,2,3,4-tetrahydroxanthene-1-carboxylate
(3s)-4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione
4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione
(1r,3s)-5,8,10-trihydroxy-7-methoxy-1,3-dimethyl-1h,3h,4h-naphtho[2,3-c]pyran-6,9-dione
8-hydroxy-7-methoxy-10-phenyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione
(1s,2s,3s)-1,2,3,5-tetrahydroxy-7-methoxy-2-methyl-3,4-dihydro-1h-anthracene-9,10-dione
(1s)-1-[(5r)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate
1-chloro-2,4,5-trihydroxy-7-(hydroxymethyl)anthracene-9,10-dione
4-(2,3-dihydroxy-3-methylbutoxy)-9-hydroxyfuro[3,2-g]chromen-7-one
1,4-dihydroxy-6-methoxy-5,8-dioxo-3-(2-oxopropyl)naphthalene-2-carboxylic acid
methyl (3s,4r,4ar)-4,8,9-trihydroxy-3-methyl-1-oxo-3,4-dihydro-2h-xanthene-4a-carboxylate
methyl (2e)-4-hydroxy-4-(8-hydroxy-7-methoxy-2-oxochromen-3-yl)-2-methylbut-2-enoate
3,5,6,8-tetrahydroxy-7-(3-oxohexyl)naphthalene-1,2-dione
2-o-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-phenylaceticacid
{"Ingredient_id": "HBIN006164","Ingredient_name": "2-o-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-phenylaceticacid","Alias": "NA","Ingredient_formula": "C15H12O8","Ingredient_Smile": "C1=CC(=C(C=C1C(=O)OC2=CC(=CC(=C2CC(=O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5767","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,5,7,2',6'-pentahydroxy flavonol
{"Ingredient_id": "HBIN007566","Ingredient_name": "3,5,7,2',6'-pentahydroxy flavonol","Alias": "NA","Ingredient_formula": "C15H12O8","Ingredient_Smile": "C1=CC(=C(C(=C1)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)(O)O)O","Ingredient_weight": "320.25 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT19413","TCMID_id": "31765","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129892149","DrugBank_id": "NA"}
3,5,6,10-tetramethoxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaene-4,11-diol
5-(2-carboxy-3-hydroxy-5-methoxyphenyl)-4-methyl-6-oxopyran-2-carboxylic acid
4-[(2r)-2,3-dihydroxy-3-methylbutoxy]-9-hydroxyfuro[3,2-g]chromen-7-one
(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-8-methoxy-3,4-dihydro-2h-1-benzopyran-3,4,7-triol
(1r,2r,3r)-1,2,3,5-tetrahydroxy-7-methoxy-2-methyl-3,4-dihydro-1h-anthracene-9,10-dione
4,8,9a-trihydroxy-3-methoxy-4a,6-dimethyl-4h-xanthene-1,9-dione
ethyl (1r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate
1-(1-hydroxy-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl)ethyl acetate
4-chloro-1,3,10-trihydroxy-8-methoxy-6-methyl-10h-anthracen-9-one
(2s)-1-[7,8-dihydroxy-5-(hydroxymethyl)-6-methyl-2-oxochromen-3-yl]-2-methylbutane-1,3-dione
(1r)-1-[(5r)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate
3,8-dihydroxy-7,9-dimethoxy-3-methyl-1h,4h-naphtho[2,3-c]pyran-5,10-dione
methyl 4-hydroxy-4-(8-hydroxy-7-methoxy-2-oxochromen-3-yl)-2-methylbut-2-enoate
methyl 2,8-dihydroxy-6-(hydroxymethyl)-9-oxo-1,2,3,4-tetrahydroxanthene-1-carboxylate
(3ar,8as)-6-bromo-1-methyl-3a-(2-methylbut-3-en-2-yl)-2h,3h,8h,8ah-pyrrolo[2,3-b]indole
4-(2-carboxy-3-hydroxy-5-methoxyphenyl)-3-methyl-6-oxopyran-2-carboxylic acid
(2r,3's)-3'-(hydroxymethyl)-4-methoxy-3'-[(2r,3r)-3-methyl-5-oxooxolan-2-yl]spiro[1-benzofuran-2,2'-oxiran]-3-one
(1r)-dispiro[cyclopentane-1,2'-pyran-3',3''-[2,4]dioxatricyclo[7.3.1.0⁵,¹³]tridecane]-1''(13''),3,5'',7'',9'',11''-hexaene-2,6'-dione
(1s)-1-(1-hydroxy-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl)ethyl acetate
(1r,10r,11r,15r)-4-hydroxy-15-methyl-13-oxo-9,14,16-trioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-3,5,7-trien-6-yl acetate
methyl (2s,3e)-2-hydroxy-4-(8-hydroxy-7-methoxy-2-oxochromen-3-yl)-2-methylbut-3-enoate
(3s)-6,9-dihydroxy-3,7-dimethoxy-3-methyl-1h,4h-naphtho[2,3-c]pyran-5,10-dione
1,4,6,7-tetrahydroxy-2-methoxy-7-methyl-6,8-dihydro-5h-anthracene-9,10-dione
(2r,3r,4r)-2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol
methyl 5-hydroxy-7-methyl-4-oxo-2-(5-oxooxolan-2-yl)-3h-1-benzopyran-2-carboxylate
methyl (3e)-2-hydroxy-4-(7-hydroxy-8-methoxy-2-oxochromen-3-yl)-2-methylbut-3-enoate
(3r)-3-[(2r)-3,3-dichloro-2-hydroxypropyl]-8-hydroxy-6-methoxy-3,4-dihydro-2-benzopyran-1-one
methyl (2e)-4-hydroxy-4-(7-hydroxy-8-methoxy-2-oxochromen-3-yl)-2-methylbut-2-enoate
dispiro[cyclopentane-1,2'-pyran-3',3''-[2,4]dioxatricyclo[7.3.1.0⁵,¹³]tridecane]-1''(13''),3,5'',7'',9'',11''-hexaene-2,6'-dione
methyl 7-hydroxy-1-methoxy-3-methyl-10-oxo-1h,3h,4h-pyrano[4,3-b]chromene-9-carboxylate
12-hydroxy-4-methoxy-5-phenyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),4,9,11-pentaene-3,6-dione
(1s,2r,3s)-1,2,3,8-tetrahydroxy-6-methoxy-3-methyl-2,4-dihydro-1h-anthracene-9,10-dione
(5s,7s)-1,4,5,7-tetrahydroxy-2-methoxy-7-methyl-6,8-dihydro-5h-anthracene-9,10-dione
methyl (2e,4s)-4-hydroxy-4-(8-hydroxy-7-methoxy-2-oxochromen-3-yl)-2-methylbut-2-enoate
(2z,4s)-4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid
bis(5-hydroxy-1h-indol-3-yl)ethane-1,2-dione
C18H12N2O4 (320.07970320000004)
(1s)-1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-1h-cyclohexa[g]isochromene-6,9-dione
1,2,3,8-tetrahydroxy-6-methoxy-3-methyl-2,4-dihydro-1h-anthracene-9,10-dione
5,7,18,20-tetraoxa-13λ⁵-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁷,²¹]tetracosa-1(24),2,4(8),9,13,15,17(21),22-octaen-13-ylium
[C19H14NO4]+ (320.09227840000005)
8-(acetyloxy)-5-formyl-3,7-dimethyl-6-oxo-8h-isochromen-7-yl acetate
8-chloro-3-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
4,5,6,7-tetrahydroxy-3-(3-oxohexyl)naphthalene-1,2-dione
5,6,7,9-tetrahydroxy-2-methoxy-7-methyl-6,8-dihydro-5h-anthracene-1,4-dione
methyl (4s,4ar)-4,8,9-trihydroxy-6-methyl-1-oxo-3,4-dihydro-2h-xanthene-4a-carboxylate
methyl (2r,3e)-2-hydroxy-4-(7-hydroxy-8-methoxy-2-oxochromen-3-yl)-2-methylbut-3-enoate
methyl (3r,4s,4as)-4,8,9-trihydroxy-3-methyl-1-oxo-3,4-dihydro-2h-xanthene-4a-carboxylate
(7r,8s)-8-(acetyloxy)-5-formyl-3,7-dimethyl-6-oxo-8h-isochromen-7-yl acetate
3,5-dihydroxy-4-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohex-1-ene-1-carboxylic acid
(2r,3s)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
methyl (1r,2s)-2,8-dihydroxy-6-(hydroxymethyl)-9-oxo-1,2,3,4-tetrahydroxanthene-1-carboxylate
methyl (2e,4s)-4-hydroxy-4-(7-hydroxy-8-methoxy-2-oxochromen-3-yl)-2-methylbut-2-enoate
methyl 5-hydroxy-2-(3-methyl-5-oxooxolan-2-yl)-4-oxo-3h-1-benzopyran-2-carboxylate
{2-[6-bromo-1-(3-methylbut-2-en-1-yl)indol-3-yl]ethyl}(methyl)amine
(3r,4s,5r)-3,5-dihydroxy-4-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohex-1-ene-1-carboxylic acid
ethyl (2r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-2-carboxylate
2-(3,4-dihydroxy-5-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol
(3as,8ar)-6-bromo-1-methyl-3a-(2-methylbut-3-en-2-yl)-2h,3h,8h,8ah-pyrrolo[2,3-b]indole
methyl (1r,3s)-7-hydroxy-1-methoxy-3-methyl-10-oxo-1h,3h,4h-pyrano[4,3-b]chromene-9-carboxylate
7-hydroxy-8-methoxy-10-phenyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione
(3r,4s,5r)-4,5-dihydroxy-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohex-1-ene-1-carboxylic acid
(1r,2r,3s)-1,2,3,5-tetrahydroxy-7-methoxy-2-methyl-3,4-dihydro-1h-anthracene-9,10-dione
5-hydroxy-7-methoxy-8-(4-methoxy-5-oxooxolan-2-yl)-2-methylchromen-4-one
(2s,3's)-3'-(hydroxymethyl)-4-methoxy-3'-[(2r,3r)-3-methyl-5-oxooxolan-2-yl]spiro[1-benzofuran-2,2'-oxiran]-3-one
1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-1h-cyclohexa[g]isochromene-6,9-dione
(2s)-2,4,6-trihydroxy-2-[(3,4,5-trihydroxyphenyl)methyl]-1-benzofuran-3-one
1-(4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl)butyl acetate
4,7-dihydroxy-2h-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one
methyl (11s,12s)-7,12-dihydroxy-13-methyl-9-oxo-2,15-dioxatricyclo[8.5.0.0³,⁸]pentadeca-3,5,7,13-tetraene-11-carboxylate
(4r,4as,9as)-4,8,9a-trihydroxy-3-methoxy-4a,6-dimethyl-4h-xanthene-1,9-dione
methyl (2e,4r)-4-hydroxy-4-(8-hydroxy-7-methoxy-2-oxochromen-3-yl)-2-methylbut-2-enoate
6-bromo-1-methyl-3a-(2-methylbut-3-en-2-yl)-2h,3h,8h,8ah-pyrrolo[2,3-b]indole
methyl 2-hydroxy-4-(7-hydroxy-8-methoxy-2-oxochromen-3-yl)-2-methylbut-3-enoate
3,6-dihydroxy-7,9-dimethoxy-3-methyl-1h,4h-naphtho[2,3-c]pyran-5,10-dione
5,7,17,19-tetraoxa-13λ⁵-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2,4(8),9,13,15,20,22-octaen-13-ylium
[C19H14NO4]+ (320.09227840000005)